202 related articles for article (PubMed ID: 7793277)
1. The effect of recombinant human erythropoietin in treating the anemia of prematurity.
Wang TS; Lee CC; Deng HH; Lin JT; Chang JS; Lin ST
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):121-7. PubMed ID: 7793277
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
Kumar P; Shankaran S; Krishnan RG
J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
[TBL] [Abstract][Full Text] [Related]
6. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
7. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
[TBL] [Abstract][Full Text] [Related]
8. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
Lauterbach R; Kachlik P; Pawlik D; Bajorek I
Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
[TBL] [Abstract][Full Text] [Related]
12. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M
J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.
Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073
[TBL] [Abstract][Full Text] [Related]
16. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
17. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin as a treatment for anemia of prematurity.
Downey P
J Perinat Neonatal Nurs; 1997 Dec; 11(3):57-68. PubMed ID: 9451192
[TBL] [Abstract][Full Text] [Related]
20. Effects of transfusion in anemia of prematurity.
Schwarz KB; Dear PR; Gill AB; Newell SJ; Richards M
Pediatr Hematol Oncol; 2005; 22(7):551-9. PubMed ID: 16166047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
